Wojcikiewicz R J, Oberdorf J A
Department of Pharmacology, College of Medicine, SUNY Health Science Center at Syracuse, Syracuse, New York 13210-2339, USA.
J Biol Chem. 1996 Jul 12;271(28):16652-5. doi: 10.1074/jbc.271.28.16652.
Inositol 1,4,5-trisphosphate (InsP3) receptors are down-regulated in response to chronic activation of certain cell surface receptors because their degradation is accelerated. Studies on the nature of the down-regulatory process and the protease(s) responsible for receptor degradation are described here. InsP3 receptor down-regulation was not accompanied by parallel changes in the concentrations of several other relevant proteins (endoplasmic reticulum Ca2+-ATPase, 3-hydroxy-3-methylglutaryl-coenzyme A reductase, and protein kinases alpha and epsilon). Thus, the down-regulatory process selectively targets InsP3 receptors for degradation. Furthermore, down-regulation was unaffected by brefeldin A and NH4Cl, indicating that InsP3 receptor degradation occurs without removal of receptors from the endoplasmic reticulum and independently of functional lysosomes. Analysis of InsP3 receptor immunofluorescence confirmed that the receptors are not redistributed prior to or during down-regulation. Finally, of a range of protease inhibitors tested, only N-acetyl-Leu-Leu-norleucinal blocked down-regulation. Thus, cysteine protease activity accounts for InsP3 receptor degradation and analysis of proteolysis in permeabilized cells indicates that this activity is calpain. Thus, InsP3 receptor down-regulation appears to result from the highly selective calpain-mediated degradation of InsP3 receptors. Calpain activity may be stimulated by the high concentrations of Ca2+ that are thought to be found in the vicinity of activated InsP3 receptors.
肌醇1,4,5 -三磷酸(InsP3)受体在某些细胞表面受体长期激活时会下调,因为其降解加速。本文描述了对下调过程的性质以及负责受体降解的蛋白酶的研究。InsP3受体下调并未伴随其他几种相关蛋白质(内质网Ca2 + -ATP酶、3 -羟基-3 -甲基戊二酰辅酶A还原酶以及蛋白激酶α和ε)浓度的平行变化。因此,下调过程选择性地靶向InsP3受体进行降解。此外,下调不受布雷菲德菌素A和氯化铵的影响,这表明InsP3受体降解发生时,受体并未从内质网中移除,且与功能性溶酶体无关。对InsP3受体免疫荧光的分析证实,受体在下调之前或期间不会重新分布。最后,在所测试的一系列蛋白酶抑制剂中,只有N -乙酰-亮氨酰-亮氨酰-正亮氨酸能阻断下调。因此,半胱氨酸蛋白酶活性导致InsP3受体降解,对通透细胞中蛋白水解的分析表明这种活性是钙蛋白酶。因此,InsP3受体下调似乎是由钙蛋白酶介导的InsP3受体高度选择性降解所致。钙蛋白酶活性可能受到高浓度Ca2 +的刺激,而高浓度Ca2 +被认为存在于活化的InsP3受体附近。